Clinical Edge Journal Scan

Patients with non-alcoholic fatty liver disease have a lower risk for atopic dermatitis


 

Key clinical point: Patients with non-alcoholic fatty liver disease (NAFLD), especially younger patients, have a significantly decreased risk of developing atopic dermatitis (AD).

Major finding: The risk for AD was significantly lower among patients with NAFLD (adjusted hazard ratio [aHR] 0.93; P = .024), particularly those age ≤ 40 years (aHR 0.80; P < .001), compared with control individuals without NAFLD.

Study details: This retrospective cohort study included 307,743 patients with NAFLD and 1,230,972 matched control individuals without NAFLD.

Disclosures: This study was funded by the Chung Shan Medical University Hospital and China Medical University, Taiwan. The authors declared no conflicts of interest.

Source: Gau SY et al. The association between non-alcoholic fatty liver disease and atopic dermatitis: A population-based cohort study. Front Immunol. 2023;14:1171804 (Aug 18). doi: 10.3389/fimmu.2023.1171804

Recommended Reading

Atopic dermatitis may be a risk factor for GBS colonization in pregnancy
MDedge Dermatology
Almonds and almond oil
MDedge Dermatology
Company submits supplemental NDA for topical atopic dermatitis treatment
MDedge Dermatology
Dupilumab improves sleep outcomes in atopic dermatitis
MDedge Dermatology
Atopic dermatitis tied to a higher risk for inflammatory bowel disease in children and adults
MDedge Dermatology
Tralokinumab is safe and effective in older patients with atopic dermatitis
MDedge Dermatology
Atopic dermatitis increases the risk for type 2 diabetes mellitus in adults
MDedge Dermatology
Severe atopic dermatitis raises risks for cardiovascular disease and venous thromboembolism
MDedge Dermatology
Dupilumab rapidly controls atopic dermatitis symptoms in children
MDedge Dermatology
Reduction in S aureus skin infections may reduce the risk for eczema herpeticum in atopic dermatitis
MDedge Dermatology